Rankings
▼
Calendar
CYTK
Cytokinetics, Incorporated
$8B
Q2 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$6M
Gross Profit
-$4M
-67.6% margin
Operating Income
-$11M
-189.8% margin
Net Income
-$12M
-200.1% margin
EPS (Diluted)
$-0.29
QoQ Revenue Growth
-31.1%
Cash Flow
Operating Cash Flow
-$11M
Free Cash Flow
-$11M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$106M
Total Liabilities
$57M
Stockholders' Equity
$49M
Cash & Equivalents
$28M
← FY 2016
All Quarters
Q3 2016 →
CYTK Q2 2016 Earnings — Cytokinetics, Incorporated Revenue & Financial Results | Market Cap Arena